PRM_PROMACTA_ONCOLOGY
Drug
Novartis Pharma AG
Total Payments
$33,505
Transactions
15
Doctors
10
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $26,917 | 7 | 7 |
| 2019 | $6,588 | 8 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $32,267 | 8 | 96.3% |
| Travel and Lodging | $859.63 | 3 | 2.6% |
| Food and Beverage | $378.26 | 4 | 1.1% |
Top Doctors Receiving Payments for PRM_PROMACTA_ONCOLOGY
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Hematology & Oncology | New York, NY | $6,000 | 1 |
| , MD | Pediatric Hematology-Oncology | Atlanta, GA | $5,954 | 5 |
| , MD DPHIL | Internal Medicine | Boston, MA | $5,502 | 1 |
| , MD | Hematology & Oncology | Boston, MA | $3,930 | 1 |
| , M.D | Medical Oncology | Houston, TX | $3,275 | 1 |
| , MD | Hematology & Oncology | Cleveland, OH | $3,275 | 1 |
| , M.D | Hematology & Oncology | Rochester, MN | $2,475 | 1 |
| , M.D | Gynecologic Oncology | Hilliard, OH | $2,460 | 1 |
| , MD | Pediatrics | New York, NY | $556.79 | 2 |
| , MD | Internal Medicine | Cleveland, OH | $77.16 | 1 |
Ad
Manufacturing Companies
- Novartis Pharma AG $33,505
Product Information
- Type Drug
- Total Payments $33,505
- Total Doctors 10
- Transactions 15
About PRM_PROMACTA_ONCOLOGY
PRM_PROMACTA_ONCOLOGY is a drug associated with $33,505 in payments to 10 healthcare providers, recorded across 15 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2019 to 2020. In 2020, $26,917 was paid across 7 transactions to 7 doctors.
The most common payment nature for PRM_PROMACTA_ONCOLOGY is "Consulting Fee" ($32,267, 96.3% of total).